The silymarin-treated rats (Fig. 3C and F) had reduced expression of α-SMA stain in their liver tissue, indicating the resistance efficacy of this drug against liver fibrosis and protection of the liver tissues against TAA-induced injury. The gene discussed is ACTA1; the disease is Hepatic fibrosis.